Bioventus Inc (BVS)
3.97
+0.01
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
3.98
+0.01
(+0.25%)
Pre-Market: 20:00
Bioventus Debt to Equity Ratio: 2.275 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.275 |
| September 30, 2023 | 2.223 |
| June 30, 2023 | 2.106 |
| March 31, 2023 | 2.364 |
| December 31, 2022 | 1.285 |
| September 30, 2022 | 1.236 |
| June 30, 2022 | 0.8348 |
| March 31, 2022 | 0.8189 |
| December 31, 2021 | 0.7794 |
| Date | Value |
|---|---|
| September 30, 2021 | 1.164 |
| June 30, 2021 | 1.279 |
| March 31, 2021 | 1.297 |
| December 31, 2020 | 1.307 |
| September 30, 2020 | 1.350 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 1.384 |
| March 31, 2016 | 0.985 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.7794
Minimum
Dec 2021
2.364
Maximum
Mar 2023
1.447
Average
1.297
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | 0.0229 |
| Retractable Technologies Inc | 0.0155 |
| Xtant Medical Holdings Inc | 0.4243 |
| Asensus Surgical Inc | 0.00 |
| Catheter Precision Inc | 0.0087 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 810.91M |
| Total Liabilities (Quarterly) | 589.79M |
| Shareholders Equity (Quarterly) | 173.59M |
| Current Ratio | 1.527 |
| Net Debt Paydown Yield | 1.77% |